CGT9486+Sunitinib vs Sunitinib in People with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumor (GIST)
Sunitinib versus Sunitinib in people with locally advanced, unresectable, or metastatic gastrointestinal stromal tumor (GIST)
Evidence level: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Related signals
- A case report of advanced small intestinal stromal tumor with KIT gene mutation and BRCA2 deletion after multi-line treatments
- Review of Genomic Testing and SDH Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST
- Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives
- Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
- UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST)